Senti Biosciences, Inc.SNTIEarnings & Financial Report
Nasdaq
SNTI Q2 2025 Key Financial Metrics
Revenue
$1.8M
Gross Profit
N/A
Operating Profit
$-16.8M
Net Profit
$-14.7M
Gross Margin
N/A
Operating Margin
-936.3%
Net Margin
-821.2%
YoY Growth
N/A
EPS
$-0.56
Financial Flow
Senti Biosciences, Inc. Q2 2025 Financial Summary
Senti Biosciences, Inc. reported revenue of $1.8M for Q2 2025, with a net profit of $-14.7M (-821.2% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $1.8M |
|---|---|
| Net Profit | $-14.7M |
| Gross Margin | N/A |
| Operating Margin | -936.3% |
| Report Period | Q2 2025 |
Senti Biosciences, Inc. Annual Revenue by Year
Senti Biosciences, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2024 | $0 |
| 2023 | $2.0M |
| 2022 | $3.3M |
Income Statement
| Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $255000 | $0 | $0 | $0 | $0 | $0 | $1.9M | $1.8M |
| YoY Growth | -83.2% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $131.8M | $119.5M | $102.2M | $86.9M | $57.7M | $97.8M | $82.8M | $68.5M |
| Liabilities | $48.8M | $52.6M | $46.1M | $42.8M | $41.7M | $47.1M | $44.9M | $43.9M |
| Equity | $82.9M | $66.9M | $56.1M | $44.1M | $16.0M | $25.6M | $37.9M | $24.7M |
Cash Flow
| Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-15.4M | $-7.0M | $-11.7M | $-8.3M | $-7.9M | $-13.5M | $-14.1M | $-13.1M |